Evidence map›Paper›PMID 20454499›Full record

ArticleClinics (Sao Paulo, Brazil)2010

Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.

Rodrigo A Toledo, Berenice B Mendonca, Maria Candida B V Fragoso, Iberê C Soares, Madson Q Almeida, Michelle B Moraes, Delmar M Lourenço, Venâncio A F Alves, Marcello D Bronstein, Sergio P A Toledo

Abstract readCase Reports
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Genetics and epigenetics of adrenocortical tumors.Molecular and cellular endocrinology · 2014
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Familial isolated pituitary adenomas: an emerging clinical entity.Journal of endocrinological investigation · 2012
    Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rodrigo A ToledoUnidade de Endocrinologia Genética, LIM/25, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. toledorodrigo@usp.br
Berenice B Mendonca
Maria Candida B V Fragoso
Iberê C Soares
Madson Q Almeida
Michelle B Moraes
Delmar M Lourenço
Venâncio A F Alves
Marcello D Bronstein
Sergio P A Toledo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNon-pituitary tumors have been reported in a subset of patients harboring germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene. However, no detailed investigations of non-pituitary tumors of AIP-mutated patients have been reported so far. PATIENTS: We examined a MEN1- and p53-negative mother-daughter pair with acromegaly due to somatotropinoma. Subsequently, the mother developed a large virilizing adrenocortical carcinoma and a grade II B-cell non-Hodgkin's lymphoma.

designMutational analysis was performed by automated sequencing. Loss-of-heterozygosity (LOH) analysis was carried out by sequencing and microsatellite analysis. AIP expression was assessed through quantitative PCR (qPCR) and immunohistochemistry.

resultsThe functional inactivating mutation c.241C>T (R81X), which blocks the AIP protein from interacting with phosphodiesterase 4A (PDE4A), was identified in the heterozygous state in the leukocyte DNA of both patients. Analyzing the tumoral DNA revealed that the AIP wild-type allele was lost in the daughter's somatotropinoma and the mother's adrenocortical carcinoma. Both tumors displayed low AIP protein expression levels. Low AIP gene expression was confirmed by qPCR in the adrenocortical carcinoma. No evidence of LOH was observed in the DNA sample from the mother's B-cell lymphoma, and this tumor displayed normal AIP immunostaining.

conclusionsOur study presents the first molecular analysis of non-pituitary tumors in AIP-mutated patients. The finding of AIP inactivation in the adrenocortical tumor suggests that further investigation of the potential role of this recently identified tumor suppressor gene in non-pituitary tumors, mainly in those tumors in which the cAMP and the 11q13 locus are implicated, is likely to be worthwhile.

Indexed as

AcromegalyAdenomaAdolescentAdrenocortical CarcinomaAdultFemaleGene ExpressionGenes, p53Germ-Line MutationGrowth Hormone-Secreting Pituitary AdenomaHumansIntracellular Signaling Peptides and ProteinsLoss of HeterozygosityMultiple Endocrine Neoplasia Type 1Pituitary NeoplasmsPolymerase Chain Reactionaryl hydrocarbon receptor-interacting proteinIntracellular Signaling Peptides and ProteinsAcromegalyAdrenocortical tumorAIPFIPApituitary tumor

Identifiers

PMID20454499
PMCPMC2862671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.